logo BDSP

Base documentaire

  1. Risk of cancer among paper recycling workers.

    Article - En anglais

    Objectives-Studies in traditional paper mills have indicated an excess cancer risk, and mutagenic compounds have been identified in the industry.

    No studies have reported on risk of cancer in paper recycling.

    Therefore the cancer incidence in Danish paper recycling mills was investigated.

    Methods-5377 employees in five paper recycling plants were included in a historical cohort study.

    The workers had been employed in paper recycling in 1965-90, and the cohort was followed up until 31 December 1993.

    The expected number of cancer cases was calculated from national rates.


    There was significantly more pharyngeal cancer among male workers (seven observed (standardised incidence ratio (SIR) 3.33,95% confidence interval (95% CI) 1.34 to 6.87)). There was slightly more lung cancer among male workers in production (39 observed, SIR 1.21,95% CI 0.86 to 1.65).

    Risk ofHodgkin's disease was doubled in male production worker (four observed, SIR 1.90,95% CI 0.51 to 4.85).

    Conclusions-The increased risk of pharyngeal cancer found in this study is interesting but may be influenced by confounders such as smoking and alcohol intake.

    This study also indicates an excess risk of Hodgkin's disease, which is in accordance with some studies in the traditional paper mills.

    As this is the first report on risk of cancer in paper recycling, further studies are needed.

    Mots-clés Pascal : Industrie papier, Matériau recyclé, Toxicité, Carcinogène, Homme, Hodgkin maladie, Epidémiologie, Tumeur maligne, Etude cohorte, Danemark, Europe, Exposition professionnelle, Médecine travail, Hémopathie maligne, Lymphoprolifératif syndrome, Lymphome

    Mots-clés Pascal anglais : Paper industry, Recycled material, Toxicity, Carcinogen, Human, Hodgkin disease, Epidemiology, Malignant tumor, Cohort study, Denmark, Europe, Occupational exposure, Occupational medicine, Malignant hemopathy, Lymphoproliferative syndrome, Lymphoma

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0504018

    Code Inist : 002B04B. Création : 13/02/1998.